Mylan says patent office cancels Sanofi's Lantus patents

Mylan N.V. said on Thursday the U.S. Patent and Trademark Office invalidated French drug company Sanofi's formulation patents on its blockbuster insulin drug Lantus, ruling in favor of the U.S. drugmaker.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news